Recent advances in managing non-small-cell lung cancer .4. Chemotherapy of metastatic cancer

被引：3

作者：

Clarke, SJ ^{[1
]}

Boyer, MJ ^{[1
]}

机构：

[1] SYDNEY CANC CTR,DEPT MED ONCOL,SYDNEY,NSW,AUSTRALIA

来源：

MEDICAL JOURNAL OF AUSTRALIA | 1997年 / 166卷

关键词：

D O I：

10.5694/j.1326-5377.1997.tb123326.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Chemotherapy has been shown to prolong survival and to be cost effective in the palliative treatment of non-small-cell lung cancer. A meta-analysis of 11 randomised trials has found a small benefit from combination chemotherapy in advanced NSCLC, increasing one-year survival rates from 5% to 15%. New combination regimens, especially carboplatin-paclitaxel, show higher response rates in selected patients, and promise improved survival rates, but this has yet to be confirmed in randomised trials.

引用

页码：S14 / S16

页数：3

共 21 条

[11] PHASE-II STUDY OF DOCETAXEL FOR ADVANCED OR METASTATIC PLATINUM-REFRACTORY NON-SMALL-CELL LUNG-CANCER
FOSSELLA, FV
LEE, JS
SHIN, DM
CALAYAG, M
HUBER, M
PEREZSOLER, R
MURPHY, WK
LIPPMAN, S
BENNER, S
GLISSON, B
CHASEN, M
HONG, WK
RABER, M
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (03) : 645 - 651
[12] PACLITAXEL (TAXOL) AND DOCETAXEL (TAXOTERE) - ACTIVE CHEMOTHERAPEUTIC-AGENTS IN LUNG-CANCER
FRANCIS, PA
KRIS, MG
RIGAS, JR
GRANT, SC
MILLER, VA
[J]. LUNG CANCER, 1995, 12 : S163 - S172
[13] GIACCONE G, 1996, P AN M AM SOC CLIN, V15, P373
[14] GINSBERG RJ, 1993, CANC PRINCIPLES PRAC, P673
[15] COUNTING THE COSTS OF CHEMOTHERAPY IN A NATIONAL-CANCER-INSTITUTE-OF-CANADA RANDOMIZED TRIAL IN NONSMALL-CELL LUNG-CANCER
JAAKKIMAINEN, L
GOODWIN, PJ
PATER, J
WARDE, P
MURRAY, N
RAPP, E
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (08) : 1301 - 1309
[16] KLATERSKY J, 1990, J CLIN ONCOL, V8, P1556
[17] MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO
[18] 2-6
[19] DOCETAXEL IN STAGE-III AND STAGE-IV NON-SMALL-CELL LUNG-CANCER
RIGAS, JR
[J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : S18 - S20
[20] SHEPHERD FA, 1994, SEMIN ONCOL S4, V21, pS48

← 1 2 3 →